These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23540342)
1. Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. van Besien H; Sassano A; Altman JK; Platanias LC Leuk Lymphoma; 2013 Dec; 54(12):2601-5. PubMed ID: 23540342 [TBL] [Abstract][Full Text] [Related]
2. Mevalonate Pathway and Human Cancers. Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953 [TBL] [Abstract][Full Text] [Related]
3. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925 [TBL] [Abstract][Full Text] [Related]
4. Drug development: target practice. Katsnelson A Nature; 2013 Jun; 498(7455):S8-9. PubMed ID: 23803950 [No Abstract] [Full Text] [Related]
5. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Li HY; Appelbaum FR; Willman CL; Zager RA; Banker DE Blood; 2003 May; 101(9):3628-34. PubMed ID: 12506040 [TBL] [Abstract][Full Text] [Related]
10. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease. Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949 [TBL] [Abstract][Full Text] [Related]
12. [Inhibitors of HMG CoA reductase: new modes of action, new indications?]. Essig M; Vrtovsnik F; Friedlander G Therapie; 2000; 55(1):43-9. PubMed ID: 10860000 [TBL] [Abstract][Full Text] [Related]
13. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. Arnaud C; Veillard NR; Mach F Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754 [TBL] [Abstract][Full Text] [Related]
14. [The anticancer properties of statins]. Sławińska A; Kandefer-Szerszeń M Postepy Hig Med Dosw (Online); 2008 Aug; 62():393-404. PubMed ID: 18688209 [TBL] [Abstract][Full Text] [Related]
15. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395 [TBL] [Abstract][Full Text] [Related]
16. Potential antitumor effects of statins (Review). Jakobisiak M; Golab J Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986 [TBL] [Abstract][Full Text] [Related]
17. Statins and cancer. Vallianou NG; Kostantinou A; Kougias M; Kazazis C Anticancer Agents Med Chem; 2014 Jun; 14(5):706-12. PubMed ID: 24295174 [TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach. Dimitroulakos J; Nohynek D; Backway KL; Hedley DW; Yeger H; Freedman MH; Minden MD; Penn LZ Blood; 1999 Feb; 93(4):1308-18. PubMed ID: 9949174 [TBL] [Abstract][Full Text] [Related]
19. Statins as potential therapeutic agents in multiple sclerosis. Stüve O; Prod'homme T; Youssef S; Dunn S; Neuhaus O; Weber M; Hartung HP; Steinman L; Zamvil SS Curr Neurol Neurosci Rep; 2004 May; 4(3):237-44. PubMed ID: 15102350 [TBL] [Abstract][Full Text] [Related]
20. [Effects of a lymph node extract on hemopoietic and lymphoid cells in normal state and in different forms of leukemia]. Fediakhina RF; Rybakova LP; Tutova IIu Eksp Onkol; 1990; 12(4):47-50. PubMed ID: 2379487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]